|
LEO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.601600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.043200E-04 |
| Normal-vs-Stage2 |
2.460300E-02 |
| Normal-vs-Stage3 |
9.817400E-01 |
| Normal-vs-Stage4 |
3.672000E-01 |
| Stage1-vs-Stage2 |
9.073600E-01 |
| Stage1-vs-Stage3 |
7.424100E-02 |
| Stage1-vs-Stage4 |
5.135200E-01 |
| Stage2-vs-Stage3 |
1.330640E-01 |
| Stage2-vs-Stage4 |
4.793600E-01 |
| Stage3-vs-Stage4 |
5.336600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.171500E-04 |
| Normal-vs-AfricanAmerican |
1.216610E-01 |
| Normal-vs-Asian |
6.027800E-01 |
| Caucasian-vs-AfricanAmerican |
2.214200E-01 |
| Caucasian-vs-Asian |
3.386800E-01 |
| AfricanAmerican-vs-Asian |
4.398200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82140000004605E-06 |
| Normal-vs-Female |
6.210000E-01 |
| Male-vs-Female |
7.99670000000141E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.362180E-01 |
| Normal-vs-Extreme_Weight |
4.35699999967731E-07 |
| Normal-vs-Obese |
3.249500E-02 |
| Normal-vs-Extreme_Obese |
7.015700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.999500E-02 |
| Normal_Weight-vs-Obese |
9.090200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.714200E-01 |
| Extreme_Weight-vs-Obese |
1.932460E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.531400E-01 |
| Obese-vs-Extreme_Obese |
4.022000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.940200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.059900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.83929999999899E-05 |
| Normal-vs-Age(81-100Yrs) |
1.007360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.870200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.728000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.261200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.767700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.630200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.642800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.89429999997159E-06 |
| Normal-VS-Type2 PRCC |
5.656600E-01 |
| Normal-VS-KIRP CIMP |
1.172410E-02 |
| Normal-VS-Unclassified PRCC |
4.295600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.837400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.417200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.326200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.107800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.204800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.771200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.975900E-04 |
| Normal-vs-N1 |
7.337000E-01 |
| Normal-vs-N2 |
1.030180E-02 |
| N0-vs-N1 |
5.229900E-02 |
| N0-vs-N2 |
6.436200E-01 |
| N1-vs-N2 |
2.621400E-01 |
|
|
